Plain-English translation of NCT06546111 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing whether —a supplement made from plant compounds—can help treat a common stomach infection caused by bacteria called Helicobacter pylori. All participants will receive standard antibiotic treatment, but half will also receive the plant-based supplement while the other half receive a placebo (a dummy pill). The researchers want to see if adding this medication improves how well the infection is cleared and reduces inflammation in the body.
Standard antibiotic treatment for this stomach infection doesn't work for everyone, and some patients develop antibiotic resistance. This trial explores whether this medication's anti-inflammatory properties could boost the effectiveness of standard treatment and help more patients recover successfully.
You will take three antibiotic medications twice daily for 14 days, along with either the plant-based supplement or a placebo pill, also twice daily. During the study, you'll have stool tests and blood tests to measure whether the infection has cleared and to check inflammation markers in your body. The entire treatment period lasts two weeks, and you'll need to return for follow-up testing to see how well the treatment worked.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
Egypt
Phase
Safety & dosing / Early efficacy
Sponsor
Sadat City University
Enrollment target
~46 participants
Started
October 2024
Primary completion
October 2025
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Aya Mosaad Swidan
Sadat City University